Novacyt

Yourgene Health, established in 2000 and headquartered in Manchester, UK, is a molecular diagnostics company specialising in genomic medicine. It develops, manufactures, and commercialises genetic products and services, primarily focusing on non-invasive prenatal testing (NIPT). The company's flagship product is the IONA test, an advanced NIPT screening for Down's syndrome and other genetic disorders, enabling clinical laboratories to perform their own NIPT services. Additionally, Yourgene Health offers cystic fibrosis screening, genetic disease screening products, and reproductive health tests.

IT-IS International Ltd. is a UK-based company that develops and manufactures diagnostic instruments specifically for the life sciences and food testing sectors. Founded in 2004 and located in Stokesley, it specializes in mobile polymerase chain reaction (PCR) devices. The company, which was previously known as Innovative Technologies Innovative Solutions Limited until its name change in April 2005, is a subsidiary of Novacyt S.A. Through its focus on innovation in diagnostic technology, IT-IS International aims to enhance testing capabilities in its targeted industries.

Primerdesign Ltd. is a company based in Southampton, United Kingdom, specializing in the design, manufacture, validation, and supply of real-time PCR kits and reagents. Established in 2004, Primerdesign offers a wide range of products, including qPCR detection kits for human pathogens, food safety, veterinary testing, and biothreat detection, as well as genotyping kits. Their product offerings encompass primers, probes, mastermixes, reagents, and instruments, along with tools for DNA and RNA extraction. The company also provides research and development services, including consultancy and OEM opportunities, and has developed innovative solutions like the selective mastermix known as quasa, which enhances the specificity of allele-specific PCR. Primerdesign distributes its products directly and through a network of distributors both in the UK and internationally. The company has formed a strategic partnership with Biogazelle and operates as a subsidiary of Novacyt Société Anonyme.

Lab21 is a healthcare diagnostics company focused on personalized diagnostic testing for disease identification, predisposition, and personalized medicine. Based in Cambridge, UK, Lab21 provides advanced testing services to healthcare providers, as well as the pharmaceutical and biotechnology industries, from its accredited facilities. The company offers a growing range of molecular and viral diagnostics, next-generation sequencing, pharmacogenetic testing, and patient profiling, all utilizing cutting-edge technology. This expertise enhances the capabilities of pharmaceutical and diagnostic partners, as well as supports clinicians in effectively treating and monitoring patients. Lab21 emphasizes the importance of prevention in healthcare, aiming to deliver high-quality information that offers valuable insights into drugs and patient profiles, thus contributing to the progression of personalized healthcare.

Centre de Compétences International en Tele-Imagerie designs and develops software suite for digital pathology.